25.10.2021 • NewsBioNTechMerck

BioNTech Founders in German Research Hall of Fame

Özlem Türeci and Uğur Şahin, founders and managing board members of Mainz-based BioNTech, were inducted into the Hall of Fame of German Research (Hall of Fame der deutschen Forschung) on Oct. 21. The awards ceremony in Wiesbaden, Germany, was organized by German pharmaceuticals, chemicals and life sciences group Merck together with Manager Magazin.

The principals of the company that developed the first mRNA-based Covid-19 vaccine to be approved by regulatory authorities worldwide have done outstanding research for decades and are true pioneers in medicine, Merck CEO Belén Garijo said at the ceremony. “Based on this technology, she said, “the door to an effective treatment of cancer and to new vaccines for infectious diseases is now wide open. Their work has been indispensable in bringing the Covid-19 pandemic to a halt.”

Author: Dede Williams, Freelance Journalist

 

Özlem Türeci and Uğur Şahin, founders and managing board members of Covid...
Özlem Türeci and Uğur Şahin, founders and managing board members of Covid vaccine maker BioNTech, were inducted into the Hall of Fame of German Research on Oct. 21. The awards were presented by German pharmaceuticals, chemicals and life sciences group Merck and Manager Magazin. (c) Merck Group

Company

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.